<DOC>
	<DOCNO>NCT00483730</DOCNO>
	<brief_summary>To assess clinical efficacy safety Actovegin type 2 diabetic patient symptomatic diabetic peripheral polyneuropathy 250 ml i.v . infusion daily 20 day follow oral treatment 600 mg × 3 daily 140 day .</brief_summary>
	<brief_title>Actovegin® Versus Placebo Patients With Diabetic Polyneuropathy ( AV-007-IM )</brief_title>
	<detailed_description />
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Actovegin</mesh_term>
	<criteria>The medical condition / disease study symptomatic diabetic peripheral polyneuropathy . All inclusion criterion must answer `` yes '' patient participate trial . 1 . Has patient give informed consent accord local requirement trial related activity ? A trial related activity procedure would perform routine management patient . 2 . Is patient age ≥ 18 ≤ 65 year ? 3 . Does patient suffer type 2 diabetes mellitus ? 4 . Has patient evidence symptomatic diabetic peripheral polyneuropathy , i.e . TSS ≥ 6 NISLL ≥ 2 ? 5 . Is patient 's VPT measure ≤ 30V ? 6 . Has patient adequate circulation foot evidence palpable pulse posterior tibialis artery dorsal artery foot ? 7 . Is HbA1C level le 10 % ? 8 . Is patient able make frequent clinic visit trial period ? For patient receive tricyclic antidepressant , anticonvulsant , mexiletine neuroleptic treatment neuropathic pain : 9 . Has regimen stable within last month ? For female patient childbearing potential ( childbearing potential consider menopause lasted 12 month ) : 10 . Does patient use acceptable contraceptive method ( hormonal pill , patch , implant , injection intrauterine device ) ? 11 . Is pregnancy test negative 1st dose trial medication ? ( Surgically hysterectomised surgically successfully sterilize female may include condition male patient ) . All exclusion criterion must answer `` '' patient participate trial . 1 . Does patient suffer know allergy towards Actovegin similar preparation ? 2 . Has patient asymmetrical neuropathy trunk proximal lower limb ? 3 . Does patient suffer diabetic foot ulceration infection ? 4 . Does patient suffer diabetic amyotrophy ? 5 . Does patient suffer decompensated cardiac insufficiency , pulmonary oedema , oliguria , anuria , generalise oedema ? 6 . Does patient suffer polyneuropathy due underlie cause ? 7 . Has patient hospitalise due diabetic polyneuropathy within last month ? 8 . Has patient participate trial Investigational Medicinal Product ( IMP ) device within 30 day inclusion trial ? 9 . Has patient ever use medication may etiological factor neuropathy , isoniazid , nitrofurantoin , vincristine phenytoin ? 10 . Has patient use cerebrolysin αlipoic acid receive Transcutaneous Electric Nerve Stimulation ( TENS ) acupuncture within last month ? 11 . Has patient receive opiates treatment / diabetic polyneuropathy within last month ? 12 . Does patient suffer malignancy ? 13 . Is patient nursing ? 14 . Does patient suffer mental , psychiatric condition may compromise data collection understand write verbal information give trial ? 15 . Does patient suffer present / previous chronic alcohol abuse ? 16 . Is anamnestic evidence hypothyroidism ? 17 . Is anamnestic evidence vitamin B12 deficiency ? 18 . Does patient suffer impair renal function high blood urea nitrogen ( BUN ) / increase serum creatinine ( &gt; 120 µmol/L ) ?</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>